8 completed, 2 terminated, 2 unknown, 1 recruiting. 10 Not applicable, 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 10 | Completed 6, Terminated 2, Recruiting 1, Unknown 1 |
| Phase 3 | 2 | Completed 2 |
| Phase 2 | 1 | Unknown 1 |
Follow Lymphangiography: new trials by email Literature Review of Lymphangiography trials Research Report on Lymphangiography
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma Indocyanine Green, Lymphangiography, Lymphovenous Bypass - Anatomic Stage III Breast Cancer AJCC v8, Breast Inflammatory Carcinoma | Not applicable | Recruiting | M.D. Anderson Cancer Center | 252 | 2018-08-14 | 2026-05-26 |
| Indocyanine Green Lymphangiography in Identifying Thoracic Duct During Neck Surgery Indocyanine Green Solution, Lymphangiography - Neck Dissection, Radical Lymph Node Dissection | Not applicable | Completed | Ohio State University Comprehensive Cancer Center | 48 | 2018-04-23 | 2024-01-16 |
| Utility of MR Lymphangiography in Postoperative Follow-up of Lymphedema: Comparison With Lymphoscintigraphy lymphangiography - Lymphedema | Not applicable | Unknown | Seoul National University Hospital | 7 | 2014-10-01 | 2015-09-16 |
| Injection Methods in Finding the Sentinel Lymph Node During Lymphatic Mapping and Sentinel Lymph Node Biopsy in Patients With Invasive Breast Cancer Isosulfan Blue, Lymphangiography, Technetium Tc 99m sulfur colloid - Breast Cancer | Not applicable | Completed | M.D. Anderson Cancer Center | 74 | 2005-06-01 | 2012-07-30 |
| Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical Cancer Isosulfan Blue, Lymph Node Mapping, Lymphangiography - Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma | Not applicable | Terminated | Gynecologic Oncology Group | 102 | 2004-06-01 | 2017-11-06 |
| Sentinel Lymph Node Biopsy and Primary Tumor Gene Expression Profiling in Finding Axillary Lymph Node Metastases in Women Who Have Received Neoadjuvant Therapy for Stage II, Stage III, or Stage IV Breast Cancer microarray analysis, immunohistochemistry staining method, conventional surgery - Breast Cancer | Not applicable | Completed | National Institutes of Health Clinical Center (CC) | 60 | 2004-02-01 | 2012-03-08 |
| Diagnostic Trial in Patients Who Are Undergoing Surgery for Early Stage Mouth Cancer immunohistochemistry staining method, conventional surgery, lymphangiography - Head and Neck Cancer | Not applicable | Completed | Alliance for Clinical Trials in Oncology | 161 | 2002-05-01 | 2016-12-07 |
| Interferon Alfa-2b in Treating Patients With Melanoma and Early Lymph Node Metastasis recombinant interferon alfa, lymphangiography, Observation - Melanoma (Skin) | Phase 3 | Completed | University of Alabama at Birmingham | 3000 | 1999-10-01 | 2014-01-20 |
| Lymphoscintigraphy to Detect Early Metastases in Patients With Cancer of the Mouth or Throat isosulfan blue, polymerase chain reaction, immunohistochemistry staining method - Head and Neck Cancer | Not applicable | Completed | NYU Langone Health | 1999-05-01 | 2016-03-11 | |
| Prognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast Cancer immunohistochemistry staining method, lymphangiography, sentinel lymph node biopsy - Breast Cancer | Phase 3 | Completed | Alliance for Clinical Trials in Oncology | 4590 | 1999-04-01 | 2016-07-13 |
| Sentinel Lymph Node Biopsy to Assess Axillary Lymph Nodes in Women With Stage I or Stage II Breast Cancer patent blue V dye, conventional surgery, lymphangiography - Breast Cancer | Phase 2 | Unknown | Royal Marsden NHS Foundation Trust | 1998-12-01 | 2013-11-06 | |
| Diagnostic Study to Identify Sentinel Lymph Nodes in Women With Stage I or Stage II Breast Cancer patent blue V dye, lymphangiography, radionuclide imaging - Breast Cancer | Not applicable | Terminated | UNICANCER | 200 | 1997-09-01 | 2021-02-21 |
| Diagnostic Procedure for Identifying Patients With Metastatic Colorectal Cancer isosulfan blue, lymphangiography, sentinel lymph node biopsy - Colorectal Cancer, Metastatic Cancer | Not applicable | Completed | Roswell Park Cancer Institute | 1997-04-01 | 2013-02-05 |
Breast Neoplasms (5) · Head and Neck Neoplasms (2) · Melanoma (2) · Colonic Neoplasms (1) · Colorectal Neoplasms (1) · Inflammatory Breast Neoplasms (1) · Lymphedema (1) · Mouth Neoplasms (1) · Neoplasm Metastasis (1) · Oropharyngeal Neoplasms (1) · Rectal Neoplasms (1) · Squamous Cell Carcinoma of Head and Neck (1) · Uterine Cervical Neoplasms (1)
Alliance for Clinical Trials in Oncology (2) · M.D. Anderson Cancer Center (2) · Gynecologic Oncology Group (1) · NYU Langone Health (1) · National Institutes of Health Clinical Center (CC) (1) · Ohio State University Comprehensive Cancer Center (1) · Roswell Park Cancer Institute (1) · Royal Marsden NHS Foundation Trust (1) · Seoul National University Hospital (1) · UNICANCER (1) · University of Alabama at Birmingham (1)
United States (9) · Australia (1) · France (1) · Ireland (1) · South Korea (1) · United Kingdom (1)
Armando E. Giuliano, MD (1) · Charles Levenback (1) · David N. Danforth, MD, MS (1) · Ebrahim Delpassand, MD (1) · Francisco Civantos, MD (1) · Gerald Gui, MD, MS, FRCS(Edin), FRCS(Eng) (1) · Gildy V. Babiera, MD (1) · Jean-Francois Rodier, MD (1) · John Phay, MD (1) · Mark Schaverien (1) · Marshall M. Urist, MD (1) · Miguel A. Rodriguez-Bigas, MD (1) · Moni A. Kuriakose, MD (1) · SeungHong Choi, MD,PhD (1)
PMID 12356141, PMID 16164916, PMID 16192820, PMID 16514477, PMID 20142602, PMID 20309640, PMID 21791687, PMID 22868365, PMID 32043193
P30CA016672 (2), U10CA027469 (1)